CareLit · DOI-Nachweis · Klinische Pädiatrie
Characterization of mutant ß-Catenin as a target molecule for antigen-specific immunotherapy in Wilms tumors
DOI 10.1055/s-2004-828561
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Ehrlich, M Thome, M von Knebel Doeberitz, R Koesters
ZeitschriftKlinische Pädiatrie
Ausgabe05/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Tumor cells are different from normal cells in that they express a unique set of proteins which are derived from the expression of mutated onco- and tumor suppressor genes – an invaluable source of candidate antigens for the development of targeted cancer immunotherapy. Several findings suggest that mutant ß-catenin may represent an attractive target-antigen for the development of cancer immunotherapy in Wilms tumor…
Zitieren
Zitierempfehlung
D Ehrlich, M Thome, M von Knebel Doeberitz, R Koesters (2004) Characterization of mutant ß-Catenin as a target molecule for antigen-specific immunotherapy in Wilms tumors. Klinische Pädiatrie (05). https://doi.org/10.1055/s-2004-828561
Mit CareLit weiterarbeiten